Hair Loss During Treatment of Obesity: Current State of the Problem and Potential Solutions

    September 2026 in “ Problems of Endocrinology ”
    Ekaterina Anatol'evna Troshina, L. A. Suplotova, Larisa Konstantinovna Dzeranova … Yu. Yu. Romanova
    Studysummary This article discusses the prevalence and mechanisms of hair loss associated with weight loss treatments and reports no new clinical results; it emphasizes the need for prevention and management strategies in affected patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on probl-endojournals.ru →
    Discuss this study in the Community →

    Research cited in this study 17

    1. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes Dermatology and Therapy · 2026
    2. GLP-1 Therapies and Hair Loss: A Systematic Review of Current Evidence and Implications for Counseling Science Progress · 2026
    3. Increased Risk of Hair Loss with GLP-1 Receptor Agonists: A Real-World Multicenter TrinetX Cohort Study JAAD International · 2026
    4. Risk Factors for Androgenetic Alopecia: A Systematic Review and Meta-Analysis BMC Public Health · 2026
    5. Prevalence and Predictors of Hair Shedding Among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia Skin Appendage Disorders · 2026
    6. Hair Loss Associated With Glucagon-Like Peptide-1 Receptor Agonist Use: A Systematic Review Cureus · 2025
    7. Alopecia as an Emerging Adverse Effect Associated with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: A Scoping Review Cureus · 2025
    8. Alopecia and Semaglutide: Connecting the Dots for Patient Safety Journal of Cosmetic Dermatology · 2025
    9. Exploring the Hair Loss Risk in Glucagon-Like Peptide-1 Agonists: Emerging Concerns and Clinical Implications Journal of the European Academy of Dermatology and Venereology · 2025
    10. The Effectiveness of Biotin in Therapy for Alopecia of Various Origins, and Pathologies of the Skin and Nails Meditsinskiy sovet = Medical Council · 2024
    11. GLP-1 Agonists and Hair Loss: A Call for Further Investigation International Journal of Dermatology · 2024
    12. Telogen Effluvium Associated with Weight Loss: A Single Center Retrospective Study Annals of dermatology/Annals of Dermatology · 2024
    13. The Formulation and In-Vitro Evaluation of WS Biotin, a Novel Encapsulated Form of D-Biotin with Improved Water Solubility for Hair and Skin Treatment Applications International Journal of Cosmetic Science · 2023
    14. Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation International Journal of Trichology · 2023
    15. Hair Loss After Metabolic and Bariatric Surgery: A Systematic Review and Meta-Analysis Obesity surgery · 2021
    16. Beta-Catenin Activity in the Dermal Papilla Regulates Morphogenesis and Regeneration of Hair Developmental Cell · 2010
    17. Transport of Biotin in Human Keratinocytes Journal of Investigative Dermatology · 2003